| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024723067 |
| P356 | DOI | 10.1038/NG1102-353 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/ng1102-353 |
| P698 | PubMed publication ID | 12410232 |
| P2093 | author name string | Aruna Bansal | |
| Eric Lai | |||
| Allen D Roses | |||
| Clive Bowman | |||
| Michael Mosteller | |||
| Arlene Hughes | |||
| P2860 | cites work | Genetic variations in HLA-B region and hypersensitivity reactions to abacavir | Q28214097 |
| The future of genetic studies of complex human diseases | Q29547215 | ||
| Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir | Q34117815 | ||
| Genome-based pharmacogenetics and the pharmaceutical industry | Q34743245 | ||
| Genetic epidemiology of single-nucleotide polymorphisms. | Q36783218 | ||
| Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. | Q52051237 | ||
| High-resolution haplotype structure in the human genome | Q56002085 | ||
| Haplotype tagging for the identification of common disease genes | Q59200321 | ||
| Prospects for whole-genome linkage disequilibrium mapping of common disease genes | Q77883184 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 353 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Medical applications of haplotype-based SNP maps: learning to walk before we run. | |
| P478 | volume | 32 |
| Q46952825 | Association between evolutionary history of angiotensinogen haplotypes and plasma levels |
| Q44796890 | Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations |
| Q28290268 | Beyond race: towards a whole-genome perspective on human populations and genetic variation |
| Q35181589 | Cardiovascular pharmacogenetics in the SNP era. |
| Q24799174 | Characterisation of the genomic architecture of human chromosome 17q and evaluation of different methods for haplotype block definition |
| Q36358798 | Comparative pharmacogenomics of antiretroviral and cytotoxic treatments. |
| Q35213734 | Genetic epidemiology, genetic maps and positional cloning |
| Q81241275 | Haplotyping in biomedicine-practical challenges |
| Q34977472 | High-throughput discovery of rare human nucleotide polymorphisms by Ecotilling |
| Q45012808 | Identification of a pharmacogenetic effect by linkage disequilibrium mapping |
| Q51956444 | Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1*03 and DRB1*04 haplotypes. |
| Q35200318 | New approaches to investigating heterogeneity in complex traits |
| Q36467321 | New strategies in drug discovery |
| Q35889605 | Pharmacogenetics and drug development: the path to safer and more effective drugs |
| Q37461474 | Pharmacogenetics of vitamin K antagonists: useful or hype? |
| Q46454351 | The impact of SNP density on fine-scale patterns of linkage disequilibrium |
| Q36980314 | The impact of genetics and genomics on public health |
| Q24810891 | The polymorphic nature of the human dopamine D4 receptor gene: a comparative analysis of known variants and a novel 27 bp deletion in the promoter region |
| Q28180092 | Using haplotype blocks to map human complex trait loci |
| Q35581055 | Will haplotype maps be useful for finding genes? |
Search more.